|
⚲
|
| Keyboard |
| Siebert John M
✚
|
|
|---|---|
| CIK # | 0001190558 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001190558] | |
| 4 | [0001190558] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Supernus Pharmaceuticals Inc | |
| Siebert John M | |
| Aradigm Corp |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Unit · derivative
|
2024-02-23 | Disposed to issuer | 3,886 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2024-02-23 | Grant | 3,886 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Units · derivative
|
2024-02-22 | Grant | 5,369 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2024-02-22 | Grant | 8,252 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Units · derivative
|
2023-02-23 | Grant | 3,886 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2023-02-23 | Grant | 6,293 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Units · derivative
|
2023-02-22 | Disposed to issuer | 3,882 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2023-02-22 | Grant | 3,882 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2022-02-22 | Grant | 6,847 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Units · derivative
|
2022-02-22 | Grant | 3,882 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Units · derivative
|
2022-02-19 | Disposed to issuer | 4,222 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2022-02-19 | Grant | 4,222 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2021-08-11 | Option exercise | 15,000 | $12.98 | 194,700 |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2021-08-11 | Option exercise | 15,000 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Restricted Stock Units · derivative
|
2021-02-19 | Grant | 4,222 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2021-02-19 | Grant | 7,365 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2020-02-21 | Grant | 5,211 | $23.99 | 125,012 |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2020-02-21 | Grant | 9,305 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Director Stock Option (Right to Buy) · derivative
|
2019-06-20 | Option exercise | 10,000 | $0.00 | |
|
Supernus Pharmaceuticals Inc SUPN
Common Stock
|
2019-06-20 | Option exercise | 10,000 | $9.13 | 91,300 |
| showing 20 of 52 most recent transactions | |||||